AI assistant
AtriCure, Inc. — Director's Dealing 2014
Jan 29, 2014
31802_dirs_2014-01-28_15f856f7-e88d-4bb0-9d94-ce248f77e580.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2014-01-24
Reporting Person: CARREL MICHAEL H (Director, President, CEO and Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-24 | Common Stock | A | 66667 | $0.00 | Acquired | 136334 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-24 | Stock Option (right to buy) | $21.04 | A | 125000 | Acquired | 2024-01-24 | Common Stock (125000) | Direct |
| 2014-01-24 | Stock Option (right to buy) | $21.04 | A | 225000 | Acquired | 2024-01-24 | Common Stock (225000) | Direct |
Footnotes
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2005 Equity Incentive Plan. The shares will vest four years from the date of grant. This award was granted pursuant to the requirements of Section 5(c) of the Employment Agreement between the Reporting Person and Issuer entered into as of November 1, 2012.
F2: The option vests and is exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. This award was granted pursuant to the requirements of Section 5(c) of the Employment Agreement between the Reporting Person and Issuer entered into as of November 1, 2012.
F3: Not applicable.
F4: Options to purchase shares in 25,000 increments vest at each Option Trigger Event. "Option Trigger Event" shall mean the volume adjusted weighted average closing price of the common stock of the Company as reported by NASDAQ (or any other exchange on which the common stock of the Company is listed) for 30 consecutive days equals or exceeds each of $10.00 per share, $12.50 per share, $15.00 per share, $17.50 per share, $20.00 per share, $25.00 per share, $30.00 per share, $35.00 per share and $40.00 per share. This award was granted pursuant to the requirements of Section 5(c) of the Employment Agreement between the Reporting Person and Issuer entered into as of November 1, 2012.